On Thursday, genetics-led consumer healthcare company 23andMe Holding Co. (NASDAQ:ME) announced a business restructuring to ...
The genetic testing company 23andMe announced it was laying off more than 200 employees, or roughly 40% of its entire ...
The struggling genetic testing company 23andMe says it will cut 40% of its workforce, or 200 jobs, as it fights for ...
The familial trend, it turned out, was linked to a genetic mutation. That meant Bill might also be at risk for the disease.
CEO Eric Lefkofsky said the purchase of Ambry Genetics will expand Tempus’ testing portfolio and bring in a fast-growing ...
Orange County’s third largest medical diagnostics and testing company is being acquired by a fast-growing Chicago-based firm ...
DNA commodification is no longer a future concern; it’s a present reality. Beyond charging users for their services, some ...
Explore how the genetic testing industry is transforming healthcare through precision medicine ensuring patient privacy and ...
Another Bay Area company has announced significant job cuts ahead of the holidays. Genetic testing firm 23andMe announced on ...